Gaudium IVF And Women Health (NSE:GAUDIUMIVF) ROCE %: 30.31% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:GAUDIUMIVF Gaudium IVF And Women Health Ltd NSE:GAUDIUMIVF
20 GF Score
Price ₹143.78
! 5 Warning Signs
View Full Analysis

What is Gaudium IVF And Women Health ROCE %?

Gaudium IVF And Women Health NSE:GAUDIUMIVF +4.99% 20 ROCE % is 30.31% as of Mar. 2026. GuruFocus rates NSE:GAUDIUMIVF with a GF Score™ of 20/100. The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Gaudium IVF And Women Health's annualized ROCE % for the quarter that ended in Mar. 2026 was 30.31%.

Gaudium IVF And Women Health  (NSE:GAUDIUMIVF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Gaudium IVF And Women Health ROCE % Related Terms

Gaudium IVF And Women Health ROCE % Historical Data

* Premium members only.

The historical data trend for Gaudium IVF And Women Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gaudium IVF And Women Health ROCE % Chart

Gaudium IVF And Women Health Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
105.18 96.00 59.57 65.56 34.80

Gaudium IVF And Women Health Quarterly Data
Mar22 Mar23 Mar24 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only 44.43 68.05 0.00 31.29 30.31
NSE:GAUDIUMIVF
20GF Score
Gaudium IVF And Women Health Ltd NSE:GAUDIUMIVF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gaudium IVF And Women Health ROCE % Calculation

Gaudium IVF And Women Health's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=356.872/( ( (885.127 - 380.108) + (1931.045 - 385.273) )/ 2 )
=356.872/( (505.019+1545.772)/ 2 )
=356.872/1025.3955
=34.80 %

Gaudium IVF And Women Health's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=468.5/( ( (0 - 0) + (1931.045 - 385.273) )/ 1 )
=468.5/( ( 0 + 1545.772 )/ 1 )
=468.5/1545.772
=30.31 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 30.31% mean?
Gaudium IVF And Women Health (NSE:GAUDIUMIVF) has a ROCE % of 30.31% as of Mar. 2026.
Is Gaudium IVF And Women Health's ROCE % too high?
Gaudium IVF And Women Health's current ROCE % is 30.31%. The Healthcare Providers & Services industry median ROCE % is 6.37. Gaudium IVF And Women Health's value of 30.31% is 375.8% above this industry median. Overall, Gaudium IVF And Women Health has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Gaudium IVF And Women Health's ROCE % compare to HCA and THC?
Gaudium IVF And Women Health's ROCE % of 30.31% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.37. Gaudium IVF And Women Health's value of 30.31% is 375.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.37, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gaudium IVF And Women Health's current ROCE % of 30.31% is 375.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gaudium IVF And Women Health's current ROCE % is 30.31%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gaudium IVF And Women Health stock overvalued right now?
Gaudium IVF And Women Health (NSE:GAUDIUMIVF) has a current ROCE % of 30.31%. The current ROCE % is 30.31% and 375.8% above the Healthcare Providers & Services industry median of 6.37. Gaudium IVF And Women Health's overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Gaudium IVF And Women Health (NSE:GAUDIUMIVF), the current ROCE % is 30.31% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gaudium IVF And Women Health Business Description

Other Exchanges 544709:India
Address B1/51, Janak Puri, B-1, Near Janakpuri East Metro Station, New Delhi, IND, 110058
Gaudium IVF And Women Health Ltd is engaged in the business of providing healthcare services mainly rendering various fertility treatments such as In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), Intracytoplasmic Sperm Injection (ICSI), Egg Freezing, and laser assisted embryo implantation, amongst others. The company derives the majority of its revenue from business of providing IVF treatment in bundled packages which includes injections, Ovum/Egg Pickup, Embryo Creation and Embryo Transfer.
20GF Score

Get the complete analysis for NSE:GAUDIUMIVF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹143.78
Price